Published on: Jan 26, 2016 at OncLive.com

Mismatch Repair-Deficient GI Tumors Respond to Anti–PD-1

By : OncLive.com

Understanding mismatch repair could help ID stomach cancer patients most likely to respond to immunotherapy.

Read More
SHARE